You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MONOAMINE OXIDASE INHIBITOR

Showing 1 - 25 of 7,715
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monoamine Oxidase Inhibitor on Phenotype of Blood Mononucleated

Recruiting
  • SARS-CoV2 Infection
  • blood sample
  • Le Kremlin-Bicêtre, France
    CHU Bicêtre
Dec 20, 2021

Structural and Functional Connectivity of Brainstem Monoamine

Completed
  • Treatment Resistant Depression
  • Monoamine Oxidase Inhibitor (MAOI)
  • Cleveland, Ohio
    Cleveland Clinic
Jun 15, 2021

MDD, Treatment Resistant Depression Trial in Toronto ([11C]SL25.1188 PET radiotracer)

Recruiting
  • Major Depressive Disorder
  • Treatment Resistant Depression
  • [11C]SL25.1188 PET radiotracer
  • Toronto, Ontario, Canada
    CAMH
Mar 31, 2022

Healthy Trial in Harrow (BI 1467335)

Completed
Has Results
  • Healthy
  • BI 1467335
  • Harrow, United Kingdom
    Northwick Park Hospital
Jun 11, 2021

Cognitive Performance, Memory, Mood Trial in Gainesville (Muscadine Wine, Muscadine Juice, Vodka)

Not yet recruiting
  • Cognitive Performance
  • +3 more
  • Muscadine Wine
  • +3 more
  • Gainesville, Florida
    Food Science and human nutrition department at University of Flo
Sep 12, 2022

Post-Authorisation Safety Study of Lesinurad

Withdrawn
  • Gout
  • Hyperuricemia
  • Zurampic®
  • Control group: xanthine oxidase inhibitor monotherapy
  • (no location specified)
Apr 15, 2021

Gout Trial in United States (SAP001)

Recruiting
  • Gout
  • San Diego, California
  • +8 more
Jan 9, 2023

Parkinson Disease, Cerebrospinal Fluid Trial run by the NINDS (drug, procedure, radiation)

Terminated
Has Results
  • Parkinson Disease
  • Cerebrospinal Fluid
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 1, 2021

Postpartum Blues, Healthy Trial in Toronto (Motherwell, Placebo)

Recruiting
  • Postpartum Blues
  • Healthy
  • Motherwell
  • Placebo
  • Toronto, Ontario, Canada
    Centre for Addiciton and Mental Health
Jun 2, 2022

Refractory Schizophrenia Trial in Pasadena (NaBen®, Placebo)

Recruiting
  • Refractory Schizophrenia
  • Pasadena, California
    For additional information regarding investigative sites for thi
Sep 10, 2021

Healthy Trial in Basel (Dimethyltryptamine (DMT), Saline)

Completed
  • Healthy
  • Basel, Basel-Stadt BS, Switzerland
    University Hospital Basel
Oct 10, 2022

Major Depression, Post Traumatic Stress Disorder Trial in Seattle (SM-001)

Not yet recruiting
  • Major Depression
  • Post Traumatic Stress Disorder
  • Seattle, Washington
    AIMS Institute
Jun 13, 2023

ECT on Monoamine Oxidase A in Depression Investigated With PET

Completed
  • Major Depression
  • Electroconvulsive therapy
  • +2 more
  • Vienna, Austria
    Department of Psychiatry and Psychotherapy
Aug 24, 2019

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Beverly Hills, Los Angeles, Pasadena

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +5 more
  • phenelzine sulfate
  • +2 more
  • Beverly Hills, California
  • +3 more
Aug 19, 2022

Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

Enrolling by invitation
  • Parkinson Disease
  • Treatment Adherence
  • Ankara, Turkey
    Ankara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023

Heart Failure Preserved Ejection Fraction, Resistant Hypertension Trial in Birmingham (Allopurinol)

Not yet recruiting
  • Heart Failure Preserved Ejection Fraction
  • Resistant Hypertension
  • Birmingham, Alabama
    Birmingham VA Medical Center, Birmingham, AL
Jun 5, 2023

MDD Trial in Toronto (Sertraline, Citalopram, N-acetylcysteine (NAC))

Completed
  • Major Depressive Disorder
  • Toronto, Ontario, Canada
    Research Imaging Centre, Centre for Addiction and Mental Health
May 22, 2019

Depressive Disorder Trial in Utrecht (Rivastigmine Transdermal Product, Sham)

Recruiting
  • Depressive Disorder
  • Rivastigmine Transdermal Product
  • Sham
  • Utrecht, Netherlands
    UMC Utrecht
Mar 2, 2023

Gout, Hyperuricemia Trial in Austin (Xanthine Oxidase Inhibitor)

Completed
  • Gout
  • Hyperuricemia
  • Xanthine Oxidase Inhibitor
  • Austin, Texas
    PPD
Jun 24, 2020

Schizophrenia Trial in Taiwan, United States (NaBen®, Placebo)

Recruiting
  • Schizophrenia
  • Dothan, Alabama
  • +22 more
Sep 10, 2021

Gout, Hyperuricemia Trial in Austin (Xanthine Oxidase Inhibitor, nonsteroidal anti-inflammatory drug)

Completed
  • Gout
  • Hyperuricemia
  • Xanthine Oxidase Inhibitor
  • nonsteroidal anti-inflammatory drug
  • Austin, Texas
    PPD
Jun 24, 2020

MDD Trial in Taichung (NMDAE, Sertraline, Placebo Cap)

Recruiting
  • Major Depressive Disorder
  • Taichung, Taiwan
    Department of Psychiatry, China Medical University Hospital
Nov 16, 2021

Selective PET Imaging of Astrocytes and Microglia in Alzheimer's

Recruiting
  • Alzheimer Disease
  • Healthy
  • Positron Emission Tomography (PET) using two PET tracer under IND
  • Houston, Texas
    Houston Methodist Research Institute
Jan 20, 2023

Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • B-Cell Lymphoproliferative Disorder
  • Boston, Massachusetts
  • +2 more
Feb 18, 2023

Obesity, Endothelial Dysfunction Trial in Tallahassee (Exercise)

Recruiting
  • Obesity
  • Endothelial Dysfunction
  • Exercise
  • Tallahassee, Florida
    Florida State University
Jun 10, 2022